These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30378790)

  • 1. Growth Hormone Treatment for Achondroplasia.
    Yorifuji T; Higuchi S; Kawakita R
    Pediatr Endocrinol Rev; 2018 Sep; 16(Suppl 1):123-128. PubMed ID: 30378790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Final adult height in long-term growth hormone-treated achondroplasia patients.
    Harada D; Namba N; Hanioka Y; Ueyama K; Sakamoto N; Nakano Y; Izui M; Nagamatsu Y; Kashiwagi H; Yamamuro M; Ishiura Y; Ogitani A; Seino Y
    Eur J Pediatr; 2017 Jul; 176(7):873-879. PubMed ID: 28501952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of growth hormone therapy for patients with skeletal dysplasia.
    Kanazawa H; Tanaka H; Inoue M; Yamanaka Y; Namba N; Seino Y
    J Bone Miner Metab; 2003; 21(5):307-10. PubMed ID: 12928832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Height Outcome of Recombinant Human Growth Hormone Treatment in Achondroplasia Children: A Meta-Analysis.
    Miccoli M; Bertelloni S; Massart F
    Horm Res Paediatr; 2016; 86(1):27-34. PubMed ID: 27355624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone (GH) treatment in achondroplasia.
    Yamate T; Kanzaki S; Tanaka H; Kubo T; Moriwake T; Inoue M; Seino Y
    J Pediatr Endocrinol; 1993; 6(1):45-52. PubMed ID: 8374688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes and medical management of achondroplasia in Japanese children: A retrospective medical record review of clinical data.
    Saitou H; Kitaoka T; Kubota T; Kanno J; Mochizuki H; Michigami T; Hasegawa K; Fujiwara I; Hamajima T; Harada D; Seki Y; Nagasaki K; Dateki S; Namba N; Tokuoka H; Pimenta JM; Cohen S; Ozono K
    Am J Med Genet A; 2024 Aug; 194(8):e63612. PubMed ID: 38554024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone treatment in 35 prepubertal children with achondroplasia: a five-year dose-response trial.
    Hertel NT; Eklöf O; Ivarsson S; Aronson S; Westphal O; Sipilä I; Kaitila I; Bland J; Veimo D; Müller J; Mohnike K; Neumeyer L; Ritzen M; Hagenäs L
    Acta Paediatr; 2005 Oct; 94(10):1402-10. PubMed ID: 16299871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comparison of the effects of short-term growth hormone treatment in patients with achondroplasia and with hypochondroplasia.
    Tanaka N; Katsumata N; Horikawa R; Tanaka T
    Endocr J; 2003 Feb; 50(1):69-75. PubMed ID: 12733711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone therapy in achondroplasia.
    Seino Y; Yamanaka Y; Shinohara M; Ikegami S; Koike M; Miyazawa M; Inoue M; Moriwake T; Tanaka H
    Horm Res; 2000; 53 Suppl 3():53-6. PubMed ID: 10971105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth and growth hormone therapy in children with achondroplasia: a two-year experience.
    Stamoyannou L; Karachaliou F; Neou P; Papataxiarchou K; Pistevos G; Bartsocas CS
    Am J Med Genet; 1997 Oct; 72(1):71-6. PubMed ID: 9295079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone therapy in achondroplasia.
    Horton WA; Hecht JT; Hood OJ; Marshall RN; Moore WV; Hollowell JG
    Am J Med Genet; 1992 Mar; 42(5):667-70. PubMed ID: 1632435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum NT-proCNP levels increased after initiation of GH treatment in patients with achondroplasia/hypochondroplasia.
    Kubota T; Wang W; Miura K; Nakayama H; Yamamoto K; Fujiwara M; Ohata Y; Tachibana M; Kitaoka T; Takakuwa S; Miyoshi Y; Namba N; Ozono K
    Clin Endocrinol (Oxf); 2016 Jun; 84(6):845-50. PubMed ID: 26814021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress report: growth hormone in skeletal dysplasia.
    Bridges NA; Brook CG
    Horm Res; 1994; 42(4-5):231-4. PubMed ID: 7868078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone therapy in achondroplasia.
    Nishi Y; Kajiyama M; Miyagawa S; Fujiwara M; Hamamoto K
    Acta Endocrinol (Copenh); 1993 May; 128(5):394-6. PubMed ID: 8317186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency.
    Grumbach MM; Bin-Abbas BS; Kaplan SL
    Horm Res; 1998; 49 Suppl 2():41-57. PubMed ID: 9730672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal dysplasia, growth hormone treatment and body proportion: comparison with other syndromic and non-syndromic short children.
    Hagenäs L; Hertel T
    Horm Res; 2003; 60 Suppl 3():65-70. PubMed ID: 14671400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Favorable Growth Hormone Treatment Response in a Young Boy with Achondroplasia.
    Krstevska-Konstantinova M; Stamatova A; Gucev Z
    Med Arch; 2016 Apr; 70(2):148-50. PubMed ID: 27147792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Present status of the use of growth hormone in short children with bone diseases (diseases of the skeleton).
    Kanaka-Gantenbein C
    J Pediatr Endocrinol Metab; 2001 Jan; 14(1):17-26. PubMed ID: 11220700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant growth hormone in children and adolescents with Turner syndrome.
    Cave CB; Bryant J; Milne R
    Cochrane Database Syst Rev; 2003; (3):CD003887. PubMed ID: 12917993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.